235 related articles for article (PubMed ID: 20063038)
41. Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin-28.
O'Carroll AM; Lolait SJ; König M; Mahan LC
Mol Pharmacol; 1992 Dec; 42(6):939-46. PubMed ID: 1362243
[TBL] [Abstract][Full Text] [Related]
42. Characterisation of the fish sst3 receptor, a member of the SRIF1 receptor family: atypical pharmacological features.
Siehler S; Zupanc GK; Seuwen K; Hoyer D
Neuropharmacology; 1999 Mar; 38(3):449-62. PubMed ID: 10219983
[TBL] [Abstract][Full Text] [Related]
43. Coexpression of somatostatin receptor subtype 5 affects internalization and trafficking of somatostatin receptor subtype 2.
Sharif N; Gendron L; Wowchuk J; Sarret P; Mazella J; Beaudet A; Stroh T
Endocrinology; 2007 May; 148(5):2095-105. PubMed ID: 17272399
[TBL] [Abstract][Full Text] [Related]
44. Visualisation of non-glycosylated somatostatin receptor two (ngsst2) immunoreactivity in the rat central nervous system.
Hervieu G; Emson PC
Brain Res Mol Brain Res; 1998 Jul; 58(1-2):138-55. PubMed ID: 9685616
[TBL] [Abstract][Full Text] [Related]
45. Effect of 17beta-estradiol on somatostatin receptor expression and inhibitory effects on growth hormone and prolactin release in rat pituitary cell cultures.
Djordjijevic D; Zhang J; Priam M; Viollet C; Gourdji D; Kordon C; Epelbaum J
Endocrinology; 1998 May; 139(5):2272-7. PubMed ID: 9564833
[TBL] [Abstract][Full Text] [Related]
46. Molecular cloning and tissue distribution of the ovine somatostatin receptor subtype 5: osst5.
Debus N; Dutour A; Boudouresque F; Vuaroqueaux V; Oliver C; Ouafik L
Domest Anim Endocrinol; 2002 Oct; 23(3):397-410. PubMed ID: 12206873
[TBL] [Abstract][Full Text] [Related]
47. Molecular cloning and functional characterization of the canine prostaglandin E2 receptor EP4 subtype.
Castleberry TA; Lu B; Smock SL; Owen TA
Prostaglandins Other Lipid Mediat; 2001 Jul; 65(4):167-87. PubMed ID: 11444589
[TBL] [Abstract][Full Text] [Related]
48. Isolation and identification of melanin-concentrating hormone as the endogenous ligand of the SLC-1 receptor.
Shimomura Y; Mori M; Sugo T; Ishibashi Y; Abe M; Kurokawa T; Onda H; Nishimura O; Sumino Y; Fujino M
Biochem Biophys Res Commun; 1999 Aug; 261(3):622-6. PubMed ID: 10441476
[TBL] [Abstract][Full Text] [Related]
49. Truncated somatostatin receptor variant sst5TMD4 confers aggressive features (proliferation, invasion and reduced octreotide response) to somatotropinomas.
Luque RM; Ibáñez-Costa A; Neto LV; Taboada GF; Hormaechea-Agulla D; Kasuki L; Venegas-Moreno E; Moreno-Carazo A; Gálvez MÁ; Soto-Moreno A; Kineman RD; Culler MD; Gahete MD; Gadelha MR; Castaño JP
Cancer Lett; 2015 Apr; 359(2):299-306. PubMed ID: 25637790
[TBL] [Abstract][Full Text] [Related]
50. Drug design at peptide receptors: somatostatin receptor ligands.
Hannon JP; Nunn C; Stolz B; Bruns C; Weckbecker G; Lewis I; Troxler T; Hurth K; Hoyer D
J Mol Neurosci; 2002; 18(1-2):15-27. PubMed ID: 11931345
[TBL] [Abstract][Full Text] [Related]
51. Distribution and characterisation of somatostatin receptor mRNA and binding sites in the brain and periphery.
Fehlmann D; Langenegger D; Schuepbach E; Siehler S; Feuerbach D; Hoyer D
J Physiol Paris; 2000; 94(3-4):265-81. PubMed ID: 11088004
[TBL] [Abstract][Full Text] [Related]
52. Small molecule somatostatin receptor subtype 4 (sst
Szőke É; Bálint M; Hetényi C; Markovics A; Elekes K; Pozsgai G; Szűts T; Kéri G; Őrfi L; Sándor Z; Szolcsányi J; Pintér E; Helyes Z
Neuropharmacology; 2020 Nov; 178():108198. PubMed ID: 32739276
[TBL] [Abstract][Full Text] [Related]
53. The new truncated somatostatin receptor variant sst5TMD4 is associated to poor prognosis in breast cancer and increases malignancy in MCF-7 cells.
Durán-Prado M; Gahete MD; Hergueta-Redondo M; Martínez-Fuentes AJ; Córdoba-Chacón J; Palacios J; Gracia-Navarro F; Moreno-Bueno G; Malagón MM; Luque RM; Castaño JP
Oncogene; 2012 Apr; 31(16):2049-61. PubMed ID: 21927030
[TBL] [Abstract][Full Text] [Related]
54. Colocalization of somatostatin receptor sst5 and insulin in rat pancreatic beta-cells.
Mitra SW; Mezey E; Hunyady B; Chamberlain L; Hayes E; Foor F; Wang Y; Schonbrunn A; Schaeffer JM
Endocrinology; 1999 Aug; 140(8):3790-6. PubMed ID: 10433240
[TBL] [Abstract][Full Text] [Related]
55. Characterization of cloned somatostatin receptors SSTR4 and SSTR5.
Raynor K; O'Carroll AM; Kong H; Yasuda K; Mahan LC; Bell GI; Reisine T
Mol Pharmacol; 1993 Aug; 44(2):385-92. PubMed ID: 8102785
[TBL] [Abstract][Full Text] [Related]
56. Differential effects of somatostatin and angiopeptin on cell proliferation.
Alderton F; Lauder H; Feniuk W; Fan TP; Humphrey PP
Br J Pharmacol; 1998 May; 124(2):323-30. PubMed ID: 9641549
[TBL] [Abstract][Full Text] [Related]
57. Identification of two novel chicken GHRH receptor splice variants: implications for the roles of aspartate 56 in the receptor activation and direct ligand receptor interaction.
Wang CY; Wang Y; Kwok AH; Leung FC
J Endocrinol; 2007 Dec; 195(3):525-36. PubMed ID: 18000314
[TBL] [Abstract][Full Text] [Related]
58. Somatostatin and its receptors from fish to mammals.
Gahete MD; Cordoba-Chacón J; Duran-Prado M; Malagón MM; Martinez-Fuentes AJ; Gracia-Navarro F; Luque RM; Castaño JP
Ann N Y Acad Sci; 2010 Jul; 1200():43-52. PubMed ID: 20633132
[TBL] [Abstract][Full Text] [Related]
59. Somatostatin receptor subtypes sst1, sst2, sst3 and sst5 expression in human pituitary, gastroentero-pancreatic and mammary tumors: comparison of mRNA analysis with receptor autoradiography.
Schaer JC; Waser B; Mengod G; Reubi JC
Int J Cancer; 1997 Mar; 70(5):530-7. PubMed ID: 9052751
[TBL] [Abstract][Full Text] [Related]
60. Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands.
Reubi JC; Waser B; Schaer JC; Laissue JA
Eur J Nucl Med; 2001 Jul; 28(7):836-46. PubMed ID: 11504080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
